Nobel laureate criticised for spruiking health supplements
One of the 1998 winners of the Nobel Prize for Medicine has been criticised for publishing a paper in a leading scientific journal without disclosing that he was endorsing a health supplement sold by Herbalife International in exchange for royalties. Louis Ignarro published an article in the June 8 issue of the Proceedings of the National Academy of Sciences about the positive effects of vitamins C and E and the amino acid arginine, all ingredients in a Herbalife product. His consulting company received at least US$1 million from the product between June 2003 and September 2004, with his signature and Nobel laureate status featuring on each bottle. The journal has decided to issue a correction to Ignarro’s article disclosing the conflict of interest.
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Are Dutch doctors too willing to euthanise people with autism and intellectual disability?
Will legalized euthanasia and assisted suicide lead to unnecessary deaths because of an able-ist bias against intellectual disability and autism?...
Euthanasia in Quebec: seamless service at a friendly funeral parlour
In Quebec, the number of cases of euthanasia has risen from 63 in 2015-2016 to 3663 in 2021-2022. Nowadays many...
Against commercial-assisted suicide
The journal Bioethics recently published an attack on commercial assisted suicide (CAS). The author, Yoann Della Croce, condemns it as...
Norway to export sperm
Danish sperm banks have grown into a successful export industry. Now Norway seems to be following the same path. The...
Denmark: parliament pressured to OK euthanasia
A proposal to legalise euthanasia in Denmark has broken the threshold of 50,000 signatures to put it before the Danish...
Australian judges need to review standards for gender dysphoria treatment
Most judges and lawyers in Australia know little about the white-hot debate amongst doctors over appropriate treatment for gender-dysphoric children....